166 related articles for article (PubMed ID: 12801136)
1. Chromosome instability and progression in urothelial cell carcinoma of the bladder.
Santos L; Pereira S; Leite RP; Souto M; Amaro T; Criado B
Acta Oncol; 2003; 42(2):169-73. PubMed ID: 12801136
[TBL] [Abstract][Full Text] [Related]
2. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
[TBL] [Abstract][Full Text] [Related]
3. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
[TBL] [Abstract][Full Text] [Related]
4. Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium.
Steidl C; Simon R; Bürger H; Brinkschmidt C; Hertle L; Böcker W; Terpe HJ
J Pathol; 2002 Sep; 198(1):115-20. PubMed ID: 12210071
[TBL] [Abstract][Full Text] [Related]
5. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.
Mazzucchelli R; Barbisan F; Stramazzotti D; Montironi R; Lopez-Beltran A; Scarpelli M
Anal Quant Cytol Histol; 2005 Jun; 27(3):143-51. PubMed ID: 16121635
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
8. Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.
Yamamoto Y; Misumi T; Eguchi S; Chochi Y; Kitahara S; Nakao M; Nagao K; Hara T; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Hum Pathol; 2011 Dec; 42(12):1923-30. PubMed ID: 21683985
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
10. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
[TBL] [Abstract][Full Text] [Related]
13. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.
Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH
Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039
[TBL] [Abstract][Full Text] [Related]
14. [Study on significance of multitargeted fluorescence in situ hybridization for urothelial carcinoma].
Xiao L; Yin YL; Zhu XZ; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):465-6. PubMed ID: 24246866
[No Abstract] [Full Text] [Related]
15. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
[TBL] [Abstract][Full Text] [Related]
16. [Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].
Moch H; Sauter G; Gudat F; Waldman F; Mihatsch MJ
Verh Dtsch Ges Pathol; 1993; 77():226-30. PubMed ID: 7511286
[TBL] [Abstract][Full Text] [Related]
17. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
[TBL] [Abstract][Full Text] [Related]
18. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy.
Bartlett JM; Adie L; Watters AD; Going JJ; Grigor KM
BJU Int; 1999 Nov; 84(7):775-9. PubMed ID: 10532970
[TBL] [Abstract][Full Text] [Related]
20. Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
Cianciulli AM; Bovani R; Leonardo F; Antenucci A; Gandolfo GM; Giannarelli D; Leonardo C; Iori F; Laurenti C
Int J Clin Lab Res; 2000; 30(1):5-11. PubMed ID: 10984125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]